February 2016

Diagnosis of Rare Bleeding Disorder Improved With Super-Resolution Microscopy

February 24, 2016

Example structured illumination microscopy (SIM) images of platelets Researchers from the National Physical Laboratory (NPL), UCL, and the Royal Free Hospital have differentiated between patients with a rare bleeding disorder and healthy [more...]

Alternative Lab-on-a-Chip Material

February 24, 2016

A close-up image of micro-scale pillars that were formed — or, photostructured — in the OSTE polymer using UV light. (Credit: KTH Royal Institute of Technology) Researchers at KTH Royal Institute of Technology have developed a new [more...]

Blood Test Could Transform TB Diagnosis, Monitor Treatment Effectiveness

February 24, 2016

Tuberculosis bacteria infect 9.6 new million patients each year. A new test developed at Stanford can accurately diagnose active cases of the disease (Image credit: MDT Magazine) Researchers at the Stanford University School of [more...]

Microfluidic Device May Speed Up DNA Insertion in Bacteria

February 21, 2016

An artist’s rendition of DNA entering bacteria (Image Credit: Nicolle Fuller, MIT news) Genetically engineering any organism requires first getting its cells to take in foreign DNA. To do this, scientists often perform a process called [more...]

NanoCellect Closes $1.75M Series A Financing Round to Begin Production of the WOLF Cell Sorter

February 10, 2016

Wolf Cell Sorter Instrument (Image Credit: NanoCellect Biomedical Inc, Click to enlarge image) San Diego, CA—Feb 4th, 2016—NanoCellect Biomedical, a developer of affordable and accessible flow cytometry and cell sorting technology for [more...]

BD Launches BD FACSymphony™ High-Speed Cell Analyzer to Enable Identification and Analysis of Rare Cell Types

February 10, 2016

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD FACSymphony™ system, a novel cell analyzer enabling the simultaneous measurement of up to 50 different [more...]

Bio-Rad Expands Its Cell Biology Portfolio With High Performance Flow Cytometer

February 8, 2016

Bio-Rad Laboratories, Inc. (NYSE: BIO) and (NYSE: BIO.B) and Propel Labs today announced that Bio-Rad has acquired a high performance analytical flow cytometer platform from Propel Labs that will enable advanced and novice users to perform [more...]

Muscles on-a-Chip Provide Insight Into Cardiac Stem Cell Therapies

February 8, 2016

A two cell microtissue consisting of a mouse embryonic stem cell-derived cardiomyocyte and a mouse neonatal cardiomyocyte. The lower panel shows the traction forces produced when the two cells contract; the stronger, neonatal [more...]

Optical Tweezers Help Determine That Red Blood Cells Move Without External Force

February 7, 2016

In experiments and computer simulations, researchers repeatedly deformed red blood cells, let them “wriggle,” and then analyzed their behavior. Three tiny spheres hold the cells in place during the process, while the movements of the [more...]

Edited Stem Cells Offer Hope Of Precision Therapy For Blindness

February 7, 2016

Skin cells from a patient with X-linked Retinitis Pigmentosa were transformed into induced pluripotent stem cells and the blindness-causing point mutation in the RPGR gene was corrected using CRISPR/Cas9 (Image credit: Vinit Mahajan) A [more...]

Invasive Measurement of Blood Glucose No Longer Necessary

February 5, 2016

A group of researchers, led by Prof. Yuji Matsuura of Tohoku University’s Graduate School of Biomedical Engineering, has developed a method of measuring blood glucose using far infrared light, which is both harmless and non-invasive. [more...]

FluidFM Micro Metal 3D Printing Firm Spun Off by ETH Zurich

February 5, 2016

ETH Zurich has developed some of the most exciting 3D printing research we’ve covered on 3DPI and, today, they’ve announced the spin off of at least one of those research endeavors into an independent business. And that business is an [more...]

Abbott’s $5.8 Billion Deal for Alere Is Device Sector’s Latest

February 2, 2016

Abbott Laboratories agreed to buy Alere Inc. for $56 a share, or about $5.8 billion, to become the leader in the market for rapid medical tests and adding another deal to a long list in the fast-consolidating medical devices and technology [more...]